These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 9802885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [Abstract] [Full Text] [Related]

  • 4. Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma.
    Lockhart DC, Chan AK, Mak S, Joo HG, Daust HA, Carritte A, Douville CC, Goedegebuure PS, Eberlein TJ.
    Surgery; 2001 Jun; 129(6):749-56. PubMed ID: 11391375
    [Abstract] [Full Text] [Related]

  • 5. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.
    Tucek-Szabo CL, Andjelić S, Lacy E, Elkon KB, Nikolić-Zugić J.
    J Immunol; 1996 Jan 01; 156(1):192-200. PubMed ID: 8598462
    [Abstract] [Full Text] [Related]

  • 6. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
    Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Bukowski RM.
    Cancer Res; 1993 Mar 15; 53(6):1380-7. PubMed ID: 8443817
    [Abstract] [Full Text] [Related]

  • 7. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun 15; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
    Tomsová M, Melichar B, Sedláková I, Steiner I.
    Gynecol Oncol; 2008 Feb 15; 108(2):415-20. PubMed ID: 18037158
    [Abstract] [Full Text] [Related]

  • 9. Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status.
    Atanackovic D, Panse J, Schafhausen P, Faltz C, Bartels K, Boeters I, Hossfeld DK, Hegewisch-Becker S.
    Leuk Res; 2005 Sep 15; 29(9):1019-27. PubMed ID: 16038728
    [Abstract] [Full Text] [Related]

  • 10. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U, Gierschner D, Welchner T, Wetterauer U.
    Anticancer Res; 2003 Sep 15; 23(1A):433-7. PubMed ID: 12680244
    [Abstract] [Full Text] [Related]

  • 11. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT, Gessner A, Miller TP, Hersh EM, Johnson CS, Cui H, Frutiger Y, Grogan TM.
    Clin Cancer Res; 2000 Oct 15; 6(10):3904-9. PubMed ID: 11051236
    [Abstract] [Full Text] [Related]

  • 12. Activated T-cell subsets in benign lymphoid hyperplasias and B-cell non-Hodgkin's lymphomas.
    Diaz JI, Edinger MG, Stoler MH, Tubbs RR.
    Am J Pathol; 1991 Sep 15; 139(3):503-9. PubMed ID: 1887860
    [Abstract] [Full Text] [Related]

  • 13. IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire.
    Soares MV, Borthwick NJ, Maini MK, Janossy G, Salmon M, Akbar AN.
    J Immunol; 1998 Dec 01; 161(11):5909-17. PubMed ID: 9834071
    [Abstract] [Full Text] [Related]

  • 14. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
    Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W, Lotze M, Whiteside TL.
    Clin Cancer Res; 2001 Mar 01; 7(3 Suppl):947s-957s. PubMed ID: 11300496
    [Abstract] [Full Text] [Related]

  • 15. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1.
    Cerwenka A, Kovar H, Majdic O, Holter W.
    J Immunol; 1996 Jan 15; 156(2):459-64. PubMed ID: 8543794
    [Abstract] [Full Text] [Related]

  • 16. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
    Khan Q, Penninger JM, Yang L, Marra LE, Kozieradzki I, Zhang L.
    J Immunol; 1999 May 15; 162(10):5860-7. PubMed ID: 10229821
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of T cell apoptosis in the rheumatoid synovium.
    Salmon M, Scheel-Toellner D, Huissoon AP, Pilling D, Shamsadeen N, Hyde H, D'Angeac AD, Bacon PA, Emery P, Akbar AN.
    J Clin Invest; 1997 Feb 01; 99(3):439-46. PubMed ID: 9022077
    [Abstract] [Full Text] [Related]

  • 18. The role of apoptosis in normal ontogenesis and solid human neoplasms.
    Kaiser HE, Bodey B.
    In Vivo; 2000 Feb 01; 14(6):789-803. PubMed ID: 11204498
    [Abstract] [Full Text] [Related]

  • 19. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S, Koike N, Adachi S.
    J Cancer Res Clin Oncol; 2002 Feb 01; 128(2):73-9. PubMed ID: 11862476
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells.
    Lin SJ, Lee CC, Cheng PJ, See LC, Kuo ML.
    Pediatr Allergy Immunol; 2009 Jun 01; 20(4):392-8. PubMed ID: 18713315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.